3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
6
Recruiting
5
Completed
4
Withdrawn
1
Not yet recruiting
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
4
Breast Neoplasms
3
Sarcoma
2
Neoplasms
2
Glioblastoma
2
Esophageal Squamous Cell Carcinoma
2
Colorectal Neoplasms
2
Brain Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Localized Resectable Adult Primary Liver Cancer
1
Jaundice
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Colonic Neoplasms
1
Clinical Stage I Gastric Cancer AJCC v8
1
Childhood Brain Neoplasm
1
Carcinoma, Hepatocellular
1
Bites and Stings
1
Biliary Tract Neoplasms
1
Adenocarcinoma Of Esophagus
1
Interventions
Sorafenib
13
Radiosurgery
9
spartalizumab
7
lenvatinib
7
Oxaliplatin
6
Gemcitabine
5
Fluorouracil
5
Radiotherapy
4
Cisplatin
4
Bevacizumab
4
atezolizumab
3
Leucovorin
3
Folfox protocol
3
Doxorubicin
3
gadolinium ethoxybenzyl DTPA
2
fludarabine
2
cabozantinib
2
Nivolumab
2
Mitomycin
2
Electroporation
2
Cyclophosphamide
2
Chemoembolization, Therapeutic
2
tremelimumab
1
toripalimab
1
tocilizumab
1
tislelizumab
1
temsirolimus
1
tazemetostat
1
sitravatinib
1
pirarubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Carcinoma, Hepatocellular
×
Surgical Procedures, Operative
×
Clear all
NCT06994299
2025-11-18
PRISM
Weill Medical College of Cornell University
Phase 2
Withdrawn